Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fertimacy is a topical vaginal gel developed by Delfran Pharmaceuticals, a South African company specializing in infertility and female healthcare. Although marketed within a fertility-focused product line, the gel is primarily indicated for the relief of feminine discomfort, itching, and odor. Its formulation is designed to maintain the natural physiological conditions of the vagina and preserve the balance of the vaginal ecosystem. The primary active ingredient is Polyhexamethylene biguanide hydrochloride (PHMB) at a 0.2% concentration, which serves as a broad-spectrum antimicrobial agent. The product is specifically formulated to be lactobacilli-sparing and matches the natural pH of the vagina. It is typically supplied in single-dose, pre-filled 3ml applicators for topical vaginal administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fertimacy.